Company filings profile · CIK 0001839970

BlossomHill Therapeutics, Inc. — SEC filings & insider activity.

Real, source-linked SEC EDGAR activity for BlossomHill Therapeutics, Inc. (BLSM): 4 filings in the last 90 days vs 1 in the prior 90 (filing-velocity rising ↑ · 4×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.

✔ Verified against the public SEC EDGAR filing record as of Aug 5, 2026. Source-linked, daily-refreshed.

Material 8-K events — BlossomHill Therapeutics, Inc.

8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).

FiledEvent
No itemized 8-K in the current window.

Watch BlossomHill Therapeutics, Inc. automatically

Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.

Insider transactions (Form 4 / 3 / 5)

FiledForm
No insider filings in the current window.

Recent filings

FiledFormDetail
Aug 4, 20268-A12B 8-A12B
Aug 3, 2026S-1/A S-1/A: AMENDMENT NO. 1
Jul 17, 2026S-1 S-1
Jun 11, 2026DRS/A
Apr 24, 2026DRS
Dec 10, 2025D Item 06b
Jan 2, 2024D Item 06b
Mar 1, 2021D Item 06b
Jan 11, 2021D Item 06b